The Hidden Cost of AI Chip Orders: Someone Must Pay for the Machines Before Customers Do

The next profitable business in artificial intelligence may not be selling more chips. It may be helping chip-equipment suppliers turn growing orders into cash.

On 11 November, Singapore-listed AEM Holdings released numbers that appear to tell a success story. Third-quarter revenue reached S$204.9 million, more than double the same period last year. Orders awaiting delivery for its Advanced Modular Parallel Tester systems exceeded S$450 million.

But another set of numbers tells a less comfortable story. AEM was carrying S$326.3 million of inventory, up 22.9% from the previous quarter. Trade and other receivables rose 28.9% to S$215.6 million. This total includes more than customer invoices and does not by itself prove that collection times worsened. Cash and cash equivalents stood at S$69 million at 30 September 2026. Cash fell by S$13.7 million during the quarter, which also included S$7.7 million in dividends and S$3.1 million in share buybacks. Payables rose to S$159.5 million, while the reported debt-to-equity ratio was 0.04. These unaudited figures do not prove financial distress. They show why inventory, payment terms and shareholder distributions must be examined together when assessing cash needs.

This analysis connects five developments: AI companies need more powerful chips; powerful chips require more testing; test-equipment orders are rising; suppliers must purchase materials before completing deliveries; and some new equipment still requires customer approval before large-scale use. The connection is not simply that testing demand is increasing. The company that manages the time between an order, delivery, customer acceptance and payment may gain an advantage over a competitor with equally good technology.

AEM is a particularly useful case because its equipment business is already producing real revenue. Its Test Cell Solutions division generated S$159.6 million in the third quarter, accounting for nearly 78% of group sales. This is not an untested AI concept. However, AEM also disclosed that qualification of its Xact memory-testing product has moved into the first half of 2027. An order book for one product does not remove the risk of a delay in another.

We think three related opportunities deserve immediate investigation.

Specialist test-equipment maintenance and calibration could create recurring service income once more machines are installed. A supplier that can inspect, repair and verify equipment quickly may help customers avoid expensive production interruptions. No newly awarded third-party maintenance contract has been verified for this opportunity.

Test interfaces, replacement components and approved consumables could benefit from a growing installed base without requiring a complete new machine sale. The strongest businesses would be those with approved customer specifications and repeat purchase records. Those third-party orders remain to be established. AEM says most current configurable demand accompanies new systems; the timing and extent of upgrades to installed systems are not yet established.

Equipment-supply financing and payment management could become valuable if a supplier’s contracted spending and collection dates create a funding gap. AEM’s larger receivables balance alone does not prove slower collection. But lending money against an order is dangerous if the order is cancellable, customer acceptance is uncertain or payment rights cannot be legally transferred.

The listed company at the centre is AEM Holdings (SGX: AWX), which closed on 11 November at S$7.05. That price was recorded before the evening business update. The stock had already gained approximately 294% over the preceding year, so we cannot honestly call the wider AI-testing opportunity undiscovered.

At S$7.05, the stock trades at approximately 21.4 to 23.5 times AEM's newly projected full-year earnings of 30 to 33 Singapore cents per share, excluding its one-off tax credit. That is a calculation from company guidance, not an independent forecast of next year's earnings.

What happens next is measurable. AEM's full-year sales forecast of S$680 million to S$705 million requires approximately S$228 million to S$253 million of fourth-quarter revenue. That is higher than its third-quarter result.

If those deliveries happen, the next test is whether operating cash flow and collection performance support the sales. Inventory or receivables need not fall in absolute terms during continued growth, so compare them with activity levels and payment timing. If deliveries slip while inventories keep rising, funding needs could grow. This is a risk to monitor, not evidence of a present funding crisis.

The early action is therefore not automatically to buy the stock. It is to compare the next shipment, cash and inventory disclosures with the company's 11 November guidance, while investigating which approved suppliers already receive repeat orders from the expanding installed base.

Report this passage